7 Analysts Assess Alkermes: What You Need To Know

Throughout the last three months, 7 analysts have evaluated Alkermes (NASDAQ:ALKS), offering a diverse set of opinions from bullish to bearish. Th...

Related Keywords

Ireland , Ashwani Verma , Akash Tewari , David Amsellem , Piper Sandler , Douglas Tsao , Joel Beatty , Analyst Firm , Hc Wainwright Co , Alkermes , Health Care , Analyst Ratings , Capitalization Analysis ,